Skip to content

Clinical trials

Completed Phase 3 Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Phase 3 Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20044
20051
20065
20071
20082
20093
20102
20111
20121
20131
20142
20162
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
GlaxoSmithKline5
Bayer4
Daiichi Sankyo Co., Ltd.3
Janssen Research & Development, LLC2
ARCA Biopharma, Inc.1
Daiichi Sankyo1
Galician Research Group on Digestive Tumors1
Italfarmaco1
National Heart, Lung, and Blood Institute (NHLBI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism32
Venous Thromboembolism9
Thrombosis8
Venous Thrombosis6
Stroke4
Embolism3
Pulmonary Embolism3
Acute Coronary Syndrome2
Atrial Fibrillation2
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.